NovaBay Pharmaceuticals Inc
NBY0.614USD
+0.021+3.45%
Market hours （ET）Quotes delayed by 15 min
3.57MMarket Cap
1.34P/E TTM
More Details of NovaBay Pharmaceuticals Inc Company
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Company Info
Ticker SymbolNBY
Company nameNovaBay Pharmaceuticals Inc
IPO dateOct 26, 2007
CEOMr. Justin M. Hall, Esq.
Number of employees14
Security typeOrdinary Share
Fiscal year-endOct 26
Address2000 Powell St Ste 1150
CityEMERYVILLE
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code94608-1804
Phone15108998800
Websitehttps://novabay.com/
Ticker SymbolNBY
IPO dateOct 26, 2007
CEOMr. Justin M. Hall, Esq.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Chief Executive Officer, Chief Compliance Officer, General Counsel, Director
Chief Executive Officer, Chief Compliance Officer, General Counsel, Director
580.00
-0.34%
Mr. Mijia (Bob) Wu
Mr. Mijia (Bob) Wu
Director
Director
122.00
--
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
92.00
--
Mr. Yongxiang (Sean) Zheng
Mr. Yongxiang (Sean) Zheng
Director
Director
50.00
--
Ms. Julie Garlikov
Ms. Julie Garlikov
Independent Director
Independent Director
50.00
--
Mr. Tommy Law
Mr. Tommy Law
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
26.00
--
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Chief Executive Officer, Chief Compliance Officer, General Counsel, Director
Chief Executive Officer, Chief Compliance Officer, General Counsel, Director
580.00
-0.34%
Mr. Mijia (Bob) Wu
Mr. Mijia (Bob) Wu
Director
Director
122.00
--
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
92.00
--
Mr. Yongxiang (Sean) Zheng
Mr. Yongxiang (Sean) Zheng
Director
Director
50.00
--
Ms. Julie Garlikov
Ms. Julie Garlikov
Independent Director
Independent Director
50.00
--
Mr. Tommy Law
Mr. Tommy Law
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
26.00
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
By RegionUSD
Name
Revenue
Proportion
United States
9.78M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
Shareholding Stats
Updated: Sun, Jul 27
Updated: Sun, Jul 27
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Poplar Point Capital Management LLC
17.54%
Sabby Management, LLC
3.75%
C2C Wealth Management, LLC
1.68%
Geode Capital Management, L.L.C.
0.60%
XTX Markets LLC
0.34%
Other
76.08%
Shareholders
Shareholders
Proportion
Poplar Point Capital Management LLC
17.54%
Sabby Management, LLC
3.75%
C2C Wealth Management, LLC
1.68%
Geode Capital Management, L.L.C.
0.60%
XTX Markets LLC
0.34%
Other
76.08%
Shareholder Types
Shareholders
Proportion
Hedge Fund
17.94%
Investment Advisor/Hedge Fund
4.35%
Investment Advisor
1.89%
Venture Capital
0.34%
Individual Investor
0.02%
Other
75.46%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
43
1.43M
24.54%
+213.78K
2025Q1
42
1.34M
22.96%
+376.59K
2024Q4
40
546.91K
11.19%
+390.20K
2024Q3
42
126.44K
2.60%
+79.02K
2024Q2
44
12.01K
0.89%
-33.08K
2024Q1
44
12.73K
1.48%
-22.10K
2023Q4
45
34.29K
18.48%
+25.73K
2023Q3
47
15.18K
15.11%
-444.00
2023Q2
47
9.53K
10.53%
-5.30K
2023Q1
51
13.02K
22.50%
-2.13K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Poplar Point Capital Management LLC
1.02M
17.54%
+19.91K
+1.99%
Jun 03, 2025
Sabby Management, LLC
218.04K
3.75%
+218.04K
--
Mar 31, 2025
C2C Wealth Management, LLC
55.00K
0.95%
+4.10K
+8.05%
Mar 31, 2025
Geode Capital Management, L.L.C.
35.00K
0.6%
+1.97K
+5.95%
Mar 31, 2025
XTX Markets LLC
19.85K
0.34%
+3.71K
+22.98%
Mar 31, 2025
Two Sigma Investments, LP
17.47K
0.3%
-13.94K
-44.37%
Mar 31, 2025
Susquehanna International Group, LLP
10.56K
0.18%
+10.56K
--
Mar 31, 2025
Tower Research Capital LLC
5.46K
0.09%
+6.00
+0.11%
Mar 31, 2025
UBS Financial Services, Inc.
749.00
0.01%
+749.00
--
Mar 31, 2025
Hall (Justin M)
580.00
0.01%
-2.00
-0.34%
Mar 18, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Nov 14, 2022
Merger
35<1
Nov 14, 2022
Merger
35<1
Date
Type
Ratio
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Nov 14, 2022
Merger
35<1
Nov 14, 2022
Merger
35<1
Nov 14, 2022
Merger
35<1
Nov 14, 2022
Merger
35<1
